Financing round-up: Anocca, Proteros biostructures, Amolyt Pharma, Evosep, LinKinVax

France: LinKinVax, a clinical-stage biotechnology company, has raised €7.3m (US$7.8m) from several individual tech executive investors including the co-founder André-Jacques Auberton-Hervé and its newest investor In-Q-Tel (IQT), the non-profit strategic investor delivering cutting-edge and critically needed technology capabilities that contribute to the national security of the US and its allies. This investment contributes to a first…

You must be a HMI Subscriber to view this content.

Subscribe Now »